ACN
56
13
PM
66
4
URI
58
-2
TSN
48
-2
EXC
56
2
NKE
28
-3
AEE
60
2
TRV
58
2
EW
37
5
ICE
62
3
PSA
58
2
CL
56
5
PH
70
-4
ZBH
68
3
AAP
21
-6
TXN
49
6
GOOG
65
8
JCI
54
-5
ADP
64
2
SEE
45
-8
ACN
56
13
PM
66
4
URI
58
-2
TSN
48
-2
EXC
56
2
NKE
28
-3
AEE
60
2
TRV
58
2
EW
37
5
ICE
62
3
PSA
58
2
CL
56
5
PH
70
-4
ZBH
68
3
AAP
21
-6
TXN
49
6
GOOG
65
8
JCI
54
-5
ADP
64
2
SEE
45
-8
Financhill
Back

Apellis Pharmaceuticals Vs. Halozyme Therapeutics Industry Stock Comparison

Sell
30

APLS
Apellis Pharmaceuticals

Last Price:
26.19
Seasonality Move:
20.78%
Sell
35

HALO
Halozyme Therapeutics

Last Price:
42.56
Seasonality Move:
17.03%
Sell
30
Apellis Pharmaceuticals (APLS) is a Sell

Is Apellis Pharmaceuticals a Buy, Sell or Hold?

  • The current Apellis Pharmaceuticals [APLS] share price is $26.18. The Score for APLS is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
  • APLS is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
35
Halozyme Therapeutics (HALO) is a Sell

Is Halozyme Therapeutics a Buy, Sell or Hold?

  • The current Halozyme Therapeutics [HALO] share price is $42.57. The Score for HALO is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
  • HALO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

APLS Stock Price Chart

What is Apellis Pharmaceuticals's stock price today?

  • The Apellis Pharmaceuticals share price today is $26.18
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and APLS is experiencing slight selling pressure.

HALO Stock Price Chart

What is Halozyme Therapeutics's stock price today?

  • The Halozyme Therapeutics share price today is $42.57
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HALO is experiencing selling pressure, which indicates risk of future bearish movement.

APLS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.53 Sell
Relative Strength Index (14 RSI): 35.91 Sell
Chaikin Money Flow: -364136 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (26.93 - 28.79) Sell
Bollinger Bands (100): (28.92 - 38.96) Sell

HALO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.04 Sell
Relative Strength Index (14 RSI): 26.84 Sell
Chaikin Money Flow: -3822578 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (48.96 - 58.72) Sell
Bollinger Bands (100): (51.86 - 60.48) Sell

APLS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 28.29 Sell
20-day SMA: 27.92 Sell
50-day SMA: 29.89 Sell
200-day SMA: 43.11 Sell
8-day EMA: 27.67 Sell
20-day EMA: 28.11 Sell
50-day EMA: 30.08 Sell
200-day EMA: 39.9 Sell

HALO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 55.27 Sell
20-day SMA: 54.02 Sell
50-day SMA: 55.85 Sell
200-day SMA: 48.97 Sell
8-day EMA: 52.24 Sell
20-day EMA: 54.19 Sell
50-day EMA: 55.13 Sell
200-day EMA: 50.65 Sell

Apellis Pharmaceuticals Earnings Growth & APLS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.11 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.75 per share, and an increase next year of $0.83 per share.

Halozyme Therapeutics Earnings Growth & HALO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.35 per share, and an increase next year of $0.56 per share.

Apellis Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Halozyme Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):